Recent trials have focused on the prevention of cancer-related sarcopenia, including exercise training [16], nutritional supplements like omega-3 fatty acids [17] or medication-based concepts such as myostatin inhibitors [18] or melanocortin-4 receptor antagonists [19]. The gene discussed is MC4R; the disease is cancer.